Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Pulmonology Reports
Published in: Current Pulmonology Reports 2/2012

01-06-2012 | Sleep Medicine (TL Lee-Chiong and V Castronovo, Section Editors)

Non-positive airway pressure therapy for obstructive sleep apnea

Authors: Behrouz Jafari, Francoise Roux

Published in: Current Pulmonology Reports | Issue 2/2012

Login to get access

Abstract

Obstructive sleep apnea (OSA) is a common disorder associated with cardiovascular morbidity. Various methods are offered to improve symptoms of OSA and its outcome. Although positive airway pressure is the most effective treatment for OSA, its clinical effectiveness is limited by patients’ compliance. Other suggested treatments for OSA focus on expanding upper airway and reducing its collapsibility. For example, mandibular advancement device (MAD) achieves this goal by mechanically protruding the mandible. Other available treatments including weight reduction, positional therapy, drugs, nasal dilators, and nasal expiratory pressure device are clearly inferior to CPAP.
Literature
1.
Bradford A, McGuire M, O’Halloran KD. Does episodic hypoxia affect upper airway dilator muscle function? Implications for the pathophysiology of obstructive sleep apnoea. Respir Physiol Neurobiol. 2005;147(2–3):223–34.PubMedCrossRef
2.
Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230–5.PubMedCrossRef
3.
Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med. 2002;165:1217–39.PubMedCrossRef
4.
Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:1378–84.PubMedCrossRef
5.
Peker Y, Kraiczi H, Hedner J, Loth S, Johansson A, Bende M. An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J. 1999;14:179–84.PubMedCrossRef
6.
Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005;353:2034–41.PubMedCrossRef
7.
Mohsenin V. Effects of gender on upper airway collapsibility and severity of obstructive sleep apnea. Sleep Med. 2003;4:523–9.PubMedCrossRef
8.
Schwab RJ, Gupta KB, Gefter WB, Metzger LJ, Hoffman EA, Pack AI. Upper airway and soft tissue anatomy in normal subjects and patients with sleep-disordered breathing. Significance of the lateral pharyngeal walls. Am J Respir Crit Care Med. 1995;152:1673–89.PubMed
9.
Jordan AS, White DP. Pharyngeal motor control and the pathogenesis of obstructive sleep apnea. Respir Physiol Neurobiol. 2008;160:1–7.PubMedCrossRef
10.
Hoffstein V, Zamel N, Phillipson EA. Lung volume dependence of pharyngeal cross-sectional area in patients with obstructive sleep apnea. Am Rev Respir Dis. 1984;130:175–8.PubMed
11.
Rubinstein I, Hoffstein V, Bradley TD. Lung volume-related changes in the pharyngeal area of obese females with and without obstructive sleep apnoea. Eur Respir J. 1989;2:344–51.PubMed
12.
Navajas D, Farre R, Rotger MM, Milic-Emili J, Sanchis J. Effect of body posture on respiratory impedance. J Appl Physiol. 1988;64:194–9.PubMed
13.
Strobel RJ, Rosen RC. Obesity and weight loss in obstructive sleep apnea: a critical review. Sleep. 1996;19:104–15.PubMed
14.
Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet. 1981;1:862–5.PubMedCrossRef
15.
Cartwright RD. Effect of sleep position on sleep apnea severity. Sleep. 1984;7:110–4.PubMed
16.
George CF, Millar TW, Kryger MH. Sleep apnea and body position during sleep. Sleep. 1988;11:90–9.PubMed
17.
McEvoy RD, Sharp DJ, Thornton AT. The effects of posture on obstructive sleep apnea. Am Rev Respir Dis. 1986;133:662–6.PubMed
18.
Petruson B. Improvement of the nasal airflow by the nasal dilator Nozovent. Rhinology. 1988;26:289–92.PubMed
19.
Phillips BA, Okeson J, Paesani D, Gilmore R. Effect of sleep position on sleep apnea and parafunctional activity. Chest. 1986;90:424–9.PubMedCrossRef
20.
Issa FG, Sullivan CE. Upper airway closing pressures in obstructive sleep apnea. J Appl Physiol. 1984;57:520–7.PubMed
21.
Shepard Jr JW, Burger CD. Nasal and oral flow-volume loops in normal subjects and patients with obstructive sleep apnea. Am Rev Respir Dis. 1990;142:1288–93.PubMed
22.
Pevernagie DA, Stanson AW, Sheedy 2nd PF, Daniels BK, Shepard Jr JW. Effects of body position on the upper airway of patients with obstructive sleep apnea. Am J Respir Crit Care Med. 1995;152:179–85.PubMed
23.
Chan AS, Lee RW, Cistulli PA. Non-positive airway pressure modalities: mandibular advancement devices/positional therapy. Proc Am Thorac Soc. 2008;5:179–84.PubMedCrossRef
24.
Richard W, Kox D, den Herder C, Laman M, van Tinteren H, de Vries N. The role of sleep position in obstructive sleep apnea syndrome. Eur Arch Otorhinolaryngol. 2006;263:946–50.PubMedCrossRef
25.
Oksenberg A, Silverberg DS, Arons E, Radwan H. Positional vs nonpositional obstructive sleep apnea patients: anthropomorphic, nocturnal polysomnographic, and multiple sleep latency test data. Chest. 1997;112:629–39.PubMedCrossRef
26.
Lindberg E, Elmasry A, Gislason T, Janson C, Bengtsson H, Hetta J, Nettelbladt M, Boman G. Evolution of sleep apnea syndrome in sleepy snorers: a population-based prospective study. Am J Respir Crit Care Med. 1999;159:2024–7.PubMed
27.
Pendlebury ST, Pepin JL, Veale D, Levy P. Natural evolution of moderate sleep apnoea syndrome: significant progression over a mean of 17 months. Thorax. 1997;52:872–8.PubMedCrossRef
28.
Maurer JT, Stuck BA, Hein G, Verse T, Hormann K. Treatment of obstructive sleep apnea with a new vest preventing the supine position. Dtsch Med Wochenschr. 2003;128:71–5.PubMedCrossRef
29.
Zuberi NA, Rekab K, Nguyen HV. Sleep apnea avoidance pillow effects on obstructive sleep apnea syndrome and snoring. Sleep Breath. 2004;8:201–7.PubMedCrossRef
30.
Cartwright R, Ristanovic R, Diaz F, Caldarelli D, Alder G. A comparative study of treatments for positional sleep apnea. Sleep. 1991;14:546–52.PubMed
31.
Cartwright RD, Lloyd S, Lilie J, Kravitz H. Sleep position training as treatment for sleep apnea syndrome: a preliminary study. Sleep. 1985;8:87–94.PubMed
32.
Wenzel S, Smith E, Leiacker R, Fischer Y. Efficacy and longterm compliance of the vest preventing the supine position in patients with obstructive sleep apnea. Laryngorhinootologie. 2007;86:579–83.PubMedCrossRef
33.
Loord H, Hultcrantz E. Positioner–a method for preventing sleep apnea. Acta Otolaryngol. 2007;127:861–8.PubMedCrossRef
34.
Berger M, Oksenberg A, Silverberg DS, Arons E, Radwan H, Iaina A. Avoiding the supine position during sleep lowers 24 h blood pressure in obstructive sleep apnea (OSA) patients. J Hum Hypertens. 1997;11:657–64.PubMedCrossRef
35.
Skinner MA, Kingshott RN, Jones DR, Homan SD, Taylor DR. Elevated posture for the management of obstructive sleep apnea. Sleep Breath. 2004;8:193–200.PubMedCrossRef
36.
Heinzer RC, Pellaton C, Rey V, Rossetti AO, Lecciso G, Haba-Rubio J, Tafti M, and Lavigne G. Positional therapy for obstructive sleep apnea: An objective measurement of patients’ usage and efficacy at home. Sleep Med. 2012.
37.
Schwartz AR, Patil SP, Laffan AM, Polotsky V, Schneider H, Smith PL. Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches. Proc Am Thorac Soc. 2008;5:185–92.PubMedCrossRef
38.
Sutherland K, Lee RW, Phillips CL, Dungan G, Yee BJ, Magnussen JS, Grunstein RR, Cistulli PA. Effect of weight loss on upper airway size and facial fat in men with obstructive sleep apnoea. Thorax. 2011;66:797–803.PubMedCrossRef
39.
Shelton KE, Woodson H, Gay S, Suratt PM. Pharyngeal fat in obstructive sleep apnea. Am Rev Respir Dis. 1993;148:462–6.PubMed
40.
Oliven A, Aspandiarov E, Gankin I, Gaitini L, Tov N. Collapsibility of the relaxed pharynx and risk of sleep apnoea. Eur Respir J. 2008;32:1309–15.PubMedCrossRef
41.
Schwartz AR, Gold AR, Schubert N, Stryzak A, Wise RA, Permutt S, Smith PL. Effect of weight loss on upper airway collapsibility in obstructive sleep apnea. Am Rev Respir Dis. 1991;144:494–8.PubMedCrossRef
42.
Hernandez TL, Ballard RD, Weil KM, Shepard TY, Scherzinger AL, Stamm ER, Sharp TA, Eckel RH. Effects of maintained weight loss on sleep dynamics and neck morphology in severely obese adults. Obesity (Silver Spring). 2009;17:84–91.CrossRef
43.
Sugerman HJ, Fairman RP, Sood RK, Engle K, Wolfe L, Kellum JM. Long-term effects of gastric surgery for treating respiratory insufficiency of obesity. Am J Clin Nutr. 1992;55:597S–601.PubMed
44.
Yee BJ, Phillips CL, Banerjee D, Caterson I, Hedner JA, Grunstein RR. The effect of sibutramine-assisted weight loss in men with obstructive sleep apnoea. Int J Obes (Lond). 2007;31:161–8.CrossRef
45.
Ferland A, Poirier P, Series F. Sibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients. Eur Respir J. 2009;34:694–701.PubMedCrossRef
46.
Phillips CL, Yee BJ, Trenell MI, Magnussen JS, Wang D, Banerjee D, Berend N, Grunstein RR. Changes in regional adiposity and cardio-metabolic function following a weight loss program with sibutramine in obese men with obstructive sleep apnea. J Clin Sleep Med. 2009;5:416–21.PubMed
47.
Lettieri CJ, Eliasson AH, Greenburg DL. Persistence of obstructive sleep apnea after surgical weight loss. J Clin Sleep Med. 2008;4:333–8.PubMed
48.
Lojander J, Mustajoki P, Ronka S, Mecklin P, Maasilta P. A nurse-managed weight reduction programme for obstructive sleep apnoea syndrome. J Intern Med. 1998;244:251–5.PubMedCrossRef
49.
Kajaste S, Brander PE, Telakivi T, Partinen M, Mustajoki P. A cognitive-behavioral weight reduction program in the treatment of obstructive sleep apnea syndrome with or without initial nasal CPAP: a randomized study. Sleep Med. 2004;5:125–31.PubMedCrossRef
50.
Rasheid S, Banasiak M, Gallagher SF, Lipska A, Kaba S, Ventimiglia D, Anderson WM, Murr MM. Gastric bypass is an effective treatment for obstructive sleep apnea in patients with clinically significant obesity. Obes Surg. 2003;13:58–61.PubMedCrossRef
51.
Busetto L, Enzi G, Inelmen EM, Costa G, Negrin V, Sergi G, Vianello A. Obstructive sleep apnea syndrome in morbid obesity: effects of intragastric balloon. Chest. 2005;128:618–23.PubMedCrossRef
52.
Charuzi I, Fraser D, Peiser J, Ovnat A, Lavie P. Sleep apnea syndrome in the morbidly obese undergoing bariatric surgery. Gastroenterol Clin North Am. 1987;16:517–9.PubMed
53.
Valencia-Flores M, Orea A, Herrera M, Santiago V, Rebollar V, Castano VA, Oseguera J, Pedroza J, Sumano J, Resendiz M, et al. Effect of bariatric surgery on obstructive sleep apnea and hypopnea syndrome, electrocardiogram, and pulmonary arterial pressure. Obes Surg. 2004;14:755–62.PubMedCrossRef
54.
Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA. 2000;284:3015–21.PubMedCrossRef
55.
Johansson K, Neovius M, Lagerros YT, Harlid R, Rossner S, Granath F, Hemmingsson E. Effect of a very low energy diet on moderate and severe obstructive sleep apnoea in obese men: a randomised controlled trial. BMJ. 2009;339:b4609.PubMedCrossRef
56.
Chan AS, Sutherland K, Schwab RJ, Zeng B, Petocz P, Lee RW, Darendeliler MA, Cistulli PA. The effect of mandibular advancement on upper airway structure in obstructive sleep apnoea. Thorax. 2010;65:726–32.PubMedCrossRef
57.
Kyung SH, Park YC, Pae EK. Obstructive sleep apnea patients with the oral appliance experience pharyngeal size and shape changes in three dimensions. Angle Orthod. 2005;75:15–22.PubMed
58.
Ng AT, Gotsopoulos H, Qian J, Cistulli PA. Effect of oral appliance therapy on upper airway collapsibility in obstructive sleep apnea. Am J Respir Crit Care Med. 2003;168:238–41.PubMedCrossRef
59.
Ferguson KA, Cartwright R, Rogers R, Schmidt-Nowara W. Oral appliances for snoring and obstructive sleep apnea: a review. Sleep. 2006;29:244–62.PubMed
60.
Hans MG, Nelson S, Luks VG, Lorkovich P, Baek SJ. Comparison of two dental devices for treatment of obstructive sleep apnea syndrome (OSAS). Am J Orthod Dentofacial Orthop. 1997;111:562–70.PubMedCrossRef
61.
Gotsopoulos H, Chen C, Qian J, Cistulli PA. Oral appliance therapy improves symptoms in obstructive sleep apnea: a randomized, controlled trial. Am J Respir Crit Care Med. 2002;166:743–8.PubMedCrossRef
62.
Barnes M, McEvoy RD, Banks S, Tarquinio N, Murray CG, Vowles N, Pierce RJ. Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med. 2004;170:656–64.PubMedCrossRef
63.
Naismith SL, Winter VR, Hickie IB, Cistulli PA. Effect of oral appliance therapy on neurobehavioral functioning in obstructive sleep apnea: a randomized controlled trial. J Clin Sleep Med. 2005;1:374–80.PubMed
64.
Petri N, Svanholt P, Solow B, Wildschiodtz G, Winkel P. Mandibular advancement appliance for obstructive sleep apnoea: results of a randomised placebo controlled trial using parallel group design. J Sleep Res. 2008;17:221–9.PubMedCrossRef
65.
Ferguson KA, Ono T, Lowe AA, Al-Majed S, Love LL, Fleetham JA. A short-term controlled trial of an adjustable oral appliance for the treatment of mild to moderate obstructive sleep apnoea. Thorax. 1997;52:362–8.PubMedCrossRef
66.
Randerath WJ, Heise M, Hinz R, Ruehle KH. An individually adjustable oral appliance vs continuous positive airway pressure in mild-to-moderate obstructive sleep apnea syndrome. Chest. 2002;122:569–75.PubMedCrossRef
67.
Tan YK, L’Estrange PR, Luo YM, Smith C, Grant HR, Simonds AK, Spiro SG, Battagel JM. Mandibular advancement splints and continuous positive airway pressure in patients with obstructive sleep apnoea: a randomized cross-over trial. Eur J Orthod. 2002;24:239–49.PubMedCrossRef
68.
Hoekema A, Stegenga B, Wijkstra PJ, van der Hoeven JH, Meinesz AF, de Bont LG. Obstructive sleep apnea therapy. J Dent Res. 2008;87:882–7.PubMedCrossRef
69.
Gagnadoux F, Fleury B, Vielle B, Petelle B, Meslier N, N’Guyen XL, Trzepizur W, Racineux JL. Titrated mandibular advancement versus positive airway pressure for sleep apnoea. Eur Respir J. 2009;34:914–20.PubMedCrossRef
70.
Engleman HM, McDonald JP, Graham D, Lello GE, Kingshott RN, Coleman EL, Mackay TW, Douglas NJ. Randomized crossover trial of two treatments for sleep apnea/hypopnea syndrome: continuous positive airway pressure and mandibular repositioning splint. Am J Respir Crit Care Med. 2002;166:855–9.PubMedCrossRef
71.
Ferguson KA, Ono T, Lowe AA, Keenan SP, Fleetham JA. A randomized crossover study of an oral appliance vs nasal-continuous positive airway pressure in the treatment of mild-moderate obstructive sleep apnea. Chest. 1996;109:1269–75.PubMedCrossRef
72.
Lam B, Sam K, Mok WY, Cheung MT, Fong DY, Lam JC, Lam DC, Yam LY, Ip MS. Randomised study of three non-surgical treatments in mild to moderate obstructive sleep apnoea. Thorax. 2007;62:354–9.PubMedCrossRef
73.
Gauthier L, Laberge L, Beaudry M, Laforte M, Rompre PH, Lavigne GJ. Efficacy of two mandibular advancement appliances in the management of snoring and mild-moderate sleep apnea: a cross-over randomized study. Sleep Med. 2009;10:329–36.PubMedCrossRef
74.
Gotsopoulos H, Kelly JJ, Cistulli PA. Oral appliance therapy reduces blood pressure in obstructive sleep apnea: a randomized, controlled trial. Sleep. 2004;27:934–41.PubMed
75.
Coruzzi P, Gualerzi M, Bernkopf E, Brambilla L, Brambilla V, Broia V, Lombardi C, Parati G. Autonomic cardiac modulation in obstructive sleep apnea: effect of an oral jaw-positioning appliance. Chest. 2006;130:1362–8.PubMedCrossRef
76.
Itzhaki S, Dorchin H, Clark G, Lavie L, Lavie P, Pillar G. The effects of 1-year treatment with a herbst mandibular advancement splint on obstructive sleep apnea, oxidative stress, and endothelial function. Chest. 2007;131:740–9.PubMedCrossRef
77.
Trzepizur W, Gagnadoux F, Abraham P, Rousseau P, Meslier N, Saumet JL, Racineux JL. Microvascular endothelial function in obstructive sleep apnea: Impact of continuous positive airway pressure and mandibular advancement. Sleep Med. 2009;10:746–52.PubMedCrossRef
78.
Hoekema A, Voors AA, Wijkstra PJ, Stegenga B, van der Hoeven JH, Tol CG, de Bont LG. Effects of oral appliances and CPAP on the left ventricle and natriuretic peptides. Int J Cardiol. 2008;128:232–9.PubMedCrossRef
79.
Hoekema A, Stegenga B, Bakker M, Brouwer WH, de Bont LG, Wijkstra PJ, van der Hoeven JH. Simulated driving in obstructive sleep apnoea-hypopnoea; effects of oral appliances and continuous positive airway pressure. Sleep Breath. 2007;11:129–38.PubMedCrossRef
80.
Mehta A, Qian J, Petocz P, Darendeliler MA, Cistulli PA. A randomized, controlled study of a mandibular advancement splint for obstructive sleep apnea. Am J Respir Crit Care Med. 2001;163:1457–61.PubMed
81.
Johnston CD, Gleadhill IC, Cinnamond MJ, Gabbey J, Burden DJ. Mandibular advancement appliances and obstructive sleep apnoea: a randomized clinical trial. Eur J Orthod. 2002;24:251–62.PubMedCrossRef
82.
Walker-Engstrom ML, Ringqvist I, Vestling O, Wilhelmsson B, Tegelberg A. A prospective randomized study comparing two different degrees of mandibular advancement with a dental appliance in treatment of severe obstructive sleep apnea. Sleep Breath. 2003;7:119–30.PubMedCrossRef
83.
Marklund M, Stenlund H, Franklin KA. Mandibular advancement devices in 630 men and women with obstructive sleep apnea and snoring: tolerability and predictors of treatment success. Chest. 2004;125:1270–8.PubMedCrossRef
84.
Liu Y, Lowe AA, Fleetham JA, Park YC. Cephalometric and physiologic predictors of the efficacy of an adjustable oral appliance for treating obstructive sleep apnea. Am J Orthod Dentofacial Orthop. 2001;120:639–47.PubMedCrossRef
85.
•• Randerath WJ, Verbraecken J, Andreas S, Bettega G, Boudewyns A, Hamans E, Jalbert F, Paoli JR, Sanner B, Smith I, et al. Non-CPAP therapies in obstructive sleep apnoea. Eur Respir J 2011;37:1000–1028. Major ERS guidelines with an overview of evidence for non-CPAP therapy of OSA. PubMedCrossRef
86.
Petit FX, Pepin JL, Bettega G, Sadek H, Raphael B, Levy P. Mandibular advancement devices: rate of contraindications in 100 consecutive obstructive sleep apnea patients. Am J Respir Crit Care Med. 2002;166:274–8.PubMedCrossRef
87.
Vanderveken OM, Devolder A, Marklund M, Boudewyns AN, Braem MJ, Okkerse W, Verbraecken JA, Franklin KA, De Backer WA, Van de Heyning PH. Comparison of a custom-made and a thermoplastic oral appliance for the treatment of mild sleep apnea. Am J Respir Crit Care Med. 2008;178:197–202.PubMedCrossRef
88.
Fleury B, Rakotonanahary D, Petelle B, Vincent G, Pelletier Fleury N, Meyer B, Lebeau B. Mandibular advancement titration for obstructive sleep apnea: optimization of the procedure by combining clinical and oximetric parameters. Chest. 2004;125:1761–7.PubMedCrossRef
89.
Kato J, Isono S, Tanaka A, Watanabe T, Araki D, Tanzawa H, Nishino T. Dose-dependent effects of mandibular advancement on pharyngeal mechanics and nocturnal oxygenation in patients with sleep-disordered breathing. Chest. 2000;117:1065–72.PubMedCrossRef
90.
Dort LC, Hadjuk E, Remmers JE. Mandibular advancement and obstructive sleep apnoea: a method for determining effective mandibular protrusion. Eur Respir J. 2006;27:1003–9.PubMed
91.
Bloch KE, Iseli A, Zhang JN, Xie X, Kaplan V, Stoeckli PW, Russi EW. A randomized, controlled crossover trial of two oral appliances for sleep apnea treatment. Am J Respir Crit Care Med. 2000;162:246–51.PubMed
92.
Dort L, Brant R. A randomized, controlled, crossover study of a noncustomized tongue retaining device for sleep disordered breathing. Sleep Breath. 2008;12:369–73.PubMedCrossRef
93.
Deane SA, Cistulli PA, Ng AT, Zeng B, Petocz P, Darendeliler MA. Comparison of mandibular advancement splint and tongue stabilizing device in obstructive sleep apnea: a randomized controlled trial. Sleep. 2009;32:648–53.PubMed
94.
Barthlen GM, Brown LK, Wiland MR, Sadeh JS, Patwari J, Zimmerman M. Comparison of three oral appliances for treatment of severe obstructive sleep apnea syndrome. Sleep Med. 2000;1:299–305.PubMedCrossRef
95.
Higurashi N, Kikuchi M, Miyazaki S, Itasaka Y. Effectiveness of a tongue-retaining device. Psychiatry Clin Neurosci. 2002;56:331–2.PubMedCrossRef
96.
Remmers JE, deGroot WJ, Sauerland EK, Anch AM. Pathogenesis of upper airway occlusion during sleep. J Appl Physiol. 1978;44:931–8.PubMed
97.
Dempsey JA, Veasey SC, Morgan BJ, O’Donnell CP. Pathophysiology of sleep apnea. Physiol Rev. 2010;90:47–112.PubMedCrossRef
98.
Schwartz AR, Eisele DW, Hari A, Testerman R, Erickson D, Smith PL. Electrical stimulation of the lingual musculature in obstructive sleep apnea. J Appl Physiol. 1996;81:643–52.PubMed
99.
Mann EA, Burnett T, Cornell S, Ludlow CL. The effect of neuromuscular stimulation of the genioglossus on the hypopharyngeal airway. Laryngoscope. 2002;112:351–6.PubMedCrossRef
100.
Oliven A, O’Hearn DJ, Boudewyns A, Odeh M, De Backer W, van de Heyning P, Smith PL, Eisele DW, Allan L, Schneider H, et al. Upper airway response to electrical stimulation of the genioglossus in obstructive sleep apnea. J Appl Physiol. 2003;95:2023–9.PubMed
101.
Oliven A, Schnall RP, Pillar G, Gavriely N, Odeh M. Sublingual electrical stimulation of the tongue during wakefulness and sleep. Respir Physiol. 2001;127:217–26.PubMedCrossRef
102.
Oliven A, Tov N, Geitini L, Steinfeld U, Oliven R, Schwartz AR, Odeh M. Effect of genioglossus contraction on pharyngeal lumen and airflow in sleep apnoea patients. Eur Respir J. 2007;30:748–58.PubMedCrossRef
103.
Isono S, Tanaka A, Nishino T. Effects of tongue electrical stimulation on pharyngeal mechanics in anaesthetized patients with obstructive sleep apnoea. Eur Respir J. 1999;14:1258–65.PubMedCrossRef
104.
Miki H, Hida W, Chonan T, Kikuchi Y, Takishima T. Effects of submental electrical stimulation during sleep on upper airway patency in patients with obstructive sleep apnea. Am Rev Respir Dis. 1989;140:1285–9.PubMedCrossRef
105.
Guilleminault C, Powell N, Bowman B, Stoohs R. The effect of electrical stimulation on obstructive sleep apnea syndrome. Chest. 1995;107:67–73.PubMedCrossRef
106.
Decker MJ, Haaga J, Arnold JL, Atzberger D, Strohl KP. Functional electrical stimulation and respiration during sleep. J Appl Physiol. 1993;75:1053–61.PubMed
107.
Eastwood PR, Barnes M, Walsh JH, Maddison KJ, Hee G, Schwartz AR, Smith PL, Malhotra A, McEvoy RD, Wheatley JR, et al. Treating obstructive sleep apnea with hypoglossal nerve stimulation. Sleep. 2011;34:1479–86.PubMed
108.
Verse T, Schwalb J, Hormann K, Stuck BA, Maurer JT. Submental transcutaneous electrical stimulation for obstructive sleep apnea. HNO. 2003;51:966–70.PubMedCrossRef
109.
Randerath WJ, Galetke W, Domanski U, Weitkunat R, Ruhle KH. Tongue-muscle training by intraoral electrical neurostimulation in patients with obstructive sleep apnea. Sleep. 2004;27:254–9.PubMed
110.
Brownell LG, West P, Sweatman P, Acres JC, Kryger MH. Protriptyline in obstructive sleep apnea: a double-blind trial. N Engl J Med. 1982;307:1037–42.PubMedCrossRef
111.
Berry RB, Yamaura EM, Gill K, Reist C. Acute effects of paroxetine on genioglossus activity in obstructive sleep apnea. Sleep. 1999;22:1087–92.PubMed
112.
Carley DW, Olopade C, Ruigt GS, Radulovacki M. Efficacy of mirtazapine in obstructive sleep apnea syndrome. Sleep. 2007;30:35–41.PubMed
113.
Hedner J, Kraiczi H, Peker Y, Murphy P. Reduction of sleep-disordered breathing after physostigmine. Am J Respir Crit Care Med. 2003;168:1246–51.PubMedCrossRef
114.
Jokic R, Klimaszewski A, Mink J, Fitzpatrick MF. Surface tension forces in sleep apnea: the role of a soft tissue lubricant: a randomized double-blind, placebo-controlled trial. Am J Respir Crit Care Med. 1998;157:1522–5.PubMed
115.
Hellgren J, Omenaas E, Gislason T, Jogi R, Franklin KA, Lindberg E, Janson C, Toren K. Perennial non-infectious rhinitis–an independent risk factor for sleep disturbances in Asthma. Respir Med. 2007;101:1015–20.PubMedCrossRef
116.
Canova CR, Downs SH, Knoblauch A, Andersson M, Tamm M, Leuppi JD. Increased prevalence of perennial allergic rhinitis in patients with obstructive sleep apnea. Respiration. 2004;71:138–43.PubMedCrossRef
117.
Zhang L, Mendoza-Sassi RA, Cesar JA, and Chadha NK. Intranasal corticosteroids for nasal airway obstruction in children with moderate to severe adenoidal hypertrophy. Cochrane Database Syst Rev 2008;CD006286.
118.
Craig TJ, Mende C, Hughes K, Kakumanu S, Lehman EB, Chinchilli V. The effect of topical nasal fluticasone on objective sleep testing and the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis. Allergy Asthma Proc. 2003;24:53–8.PubMed
119.
Kiely JL, Nolan P, McNicholas WT. Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis. Thorax. 2004;59:50–5.PubMed
120.
Clarenbach CF, Kohler M, Senn O, Thurnheer R, Bloch KE. Does nasal decongestion improve obstructive sleep apnea? J Sleep Res. 2008;17:444–9.PubMedCrossRef
121.
McNicholas WT, Tarlo S, Cole P, Zamel N, Rutherford R, Griffin D, Phillipson EA. Obstructive apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis. 1982;126:625–8.PubMed
122.
Metes A, Cole P, Hoffstein V, Miljeteig H. Nasal airway dilation and obstructed breathing in sleep. Laryngoscope. 1992;102:1053–5.PubMedCrossRef
123.
Hoijer U, Ejnell H, Hedner J, Petruson B, Eng LB. The effects of nasal dilation on snoring and obstructive sleep apnea. Arch Otolaryngol Head Neck Surg. 1992;118:281–4.PubMedCrossRef
124.
Schonhofer B, Franklin KA, Brunig H, Wehde H, Kohler D. Effect of nasal-valve dilation on obstructive sleep apnea. Chest. 2000;118:587–90.PubMedCrossRef
125.
• Kryger MH, Berry RB, and Massie CA. Long-term use of a nasal expiratory positive airway pressure (EPAP) device as a treatment for obstructive sleep apnea (OSA). J Clin Sleep Med 2011;7:449-453B. This study shows good results of using nasal EPAP in OSA patients. PubMed
126.
Colrain IM, Brooks S, Black J. A pilot evaluation of a nasal expiratory resistance device for the treatment of obstructive sleep apnea. J Clin Sleep Med. 2008;4:426–33.PubMed
127.
Rosenthal L, Massie CA, Dolan DC, Loomas B, Kram J, Hart RW. A multicenter, prospective study of a novel nasal EPAP device in the treatment of obstructive sleep apnea: efficacy and 30-day adherence. J Clin Sleep Med. 2009;5:532–7.PubMed
128.
Patel AV, Hwang D, Masdeu MJ, Chen GM, Rapoport DM, Ayappa I. Predictors of response to a nasal expiratory resistor device and its potential mechanisms of action for treatment of obstructive sleep apnea. J Clin Sleep Med. 2011;7:13–22.PubMed
129.
Berry RB, Kryger MH, Massie CA. A novel nasal expiratory positive airway pressure (EPAP) device for the treatment of obstructive sleep apnea: a randomized controlled trial. Sleep. 2011;34:479–85.PubMed
130.
White DP, Cadieux RJ, Lombard RM, Bixler EO, Kales A, Zwillich CW. The effects of nasal anesthesia on breathing during sleep. Am Rev Respir Dis. 1985;132:972–5.PubMed
131.
Basner RC, Simon PM, Schwartzstein RM, Weinberger SE, Weiss JW. Breathing route influences upper airway muscle activity in awake normal adults. J Appl Physiol. 1989;66:1766–71.PubMed
132.
Zwillich CW, Pickett C, Hanson FN, Weil JV. Disturbed sleep and prolonged apnea during nasal obstruction in normal men. Am Rev Respir Dis. 1981;124:158–60.PubMed
133.
Lavie P, Fischel N, Zomer J, Eliaschar I. The effects of partial and complete mechanical occlusion of the nasal passages on sleep structure and breathing in sleep. Acta Otolaryngol. 1983;95:161–6.PubMedCrossRef
134.
Olsen KD, Kern EB, Westbrook PR. Sleep and breathing disturbance secondary to nasal obstruction. Otolaryngol Head Neck Surg. 1981;89:804–10.PubMed
135.
Morris LG, Setlur J, Burschtin OE, Steward DL, Jacobs JB, Lee KC. Acoustic rhinometry predicts tolerance of nasal continuous positive airway pressure: a pilot study. Am J Rhinol. 2006;20:133–7.PubMed
136.
Choi JH, Kim EJ, Kim YS, Kim TH, Choi J, Kwon SY, Lee HM, Lee SH. Effectiveness of nasal surgery alone on sleep quality, architecture, position, and sleep-disordered breathing in obstructive sleep apnea syndrome with nasal obstruction. Am J Rhinol Allergy. 2011;25:338–41.PubMedCrossRef
137.
Zonato AI, Bittencourt LR, Martinho FL, Junior JF, Gregorio LC, Tufik S. Association of systematic head and neck physical examination with severity of obstructive sleep apnea-hypopnea syndrome. Laryngoscope. 2003;113:973–80.PubMedCrossRef
138.
Friedman M, Tanyeri H, La Rosa M, Landsberg R, Vaidyanathan K, Pieri S, Caldarelli D. Clinical predictors of obstructive sleep apnea. Laryngoscope. 1999;109:1901–7.PubMedCrossRef
139.
Shott SR. Evaluation and management of pediatric obstructive sleep apnea beyond tonsillectomy and adenoidectomy. Curr Opin Otolaryngol Head Neck Surg.
140.
Martinho FL, Zonato AI, Bittencourt LR, Soares MC, Silva RF, Gregorio LC, Tufik S. Obese obstructive sleep apnea patients with tonsil hypertrophy submitted to tonsillectomy. Braz J Med Biol Res. 2006;39:1137–42.PubMedCrossRef
141.
Nakata S, Miyazaki S, Ohki M, Morinaga M, Noda A, Sugiura T, Sugiura M, Teranishi M, Katayama N, Nakashima T. Reduced nasal resistance after simple tonsillectomy in patients with obstructive sleep apnea. Am J Rhinol. 2007;21:192–5.PubMedCrossRef
142.
Powell NB, Riley RW, Troell RJ, Blumen MB, Guilleminault C. Radiofrequency volumetric reduction of the tongue. A porcine pilot study for the treatment of obstructive sleep apnea syndrome. Chest. 1997;111:1348–55.PubMedCrossRef
143.
Hukins CA, Mitchell IC, Hillman DR. Radiofrequency tissue volume reduction of the soft palate in simple snoring. Arch Otolaryngol Head Neck Surg. 2000;126:602–6.PubMed
144.
Stuck BA, Sauter A, Hormann K, Verse T, Maurer JT. Radiofrequency surgery of the soft palate in the treatment of snoring. A placebo-controlled trial. Sleep. 2005;28:847–50.PubMed
145.
Amoros-Sebastia LI. Radiofrequency treatment in simple snoring: tolerance, safety and results. Acta Otorrinolaringol Esp. 2011;62:300–5.PubMedCrossRef
146.
Nelson LM. Radiofrequency treatment for obstructive tonsillar hypertrophy. Arch Otolaryngol Head Neck Surg. 2000;126:736–40.PubMed
147.
Nelson LM. Temperature-controlled radiofrequency tonsil reduction: extended follow-up. Otolaryngol Head Neck Surg. 2001;125:456–61.PubMed
148.
Friedman M, LoSavio P, Ibrahim H, Ramakrishnan V. Radiofrequency tonsil reduction: safety, morbidity, and efficacy. Laryngoscope. 2003;113:882–7.PubMedCrossRef
149.
Ericsson E, Hultcrantz E. Tonsil surgery in youths: good results with a less invasive method. Laryngoscope. 2007;117:654–61.PubMedCrossRef
150.
Won CH, Li KK, Guilleminault C. Surgical treatment of obstructive sleep apnea: upper airway and maxillomandibular surgery. Proc Am Thorac Soc. 2008;5:193–9.PubMedCrossRef
151.
Fujita S, Conway W, Zorick F, Roth T. Surgical correction of anatomic azbnormalities in obstructive sleep apnea syndrome: uvulopalatopharyngoplasty. Otolaryngol Head Neck Surg. 1981;89:923–34.PubMed
152.
• Caples SM, Rowley JA, Prinsell JR, Pallanch JF, Elamin MB, Katz SG, and Harwick JD. Surgical modifications of the upper airway for obstructive sleep apnea in adults: a systematic review and meta-analysis. Sleep 2010;33:1396–1407. Meta-analysis of surgical treatment of OSA. PubMed
153.
154.
Li HY, Wang PC, Lee LA, Chen NH, Fang TJ. Prediction of uvulopalatopharyngoplasty outcome: anatomy-based staging system versus severity-based staging system. Sleep. 2006;29:1537–41.PubMed
155.
Walker-Engstrom ML, Tegelberg A, Wilhelmsson B, Ringqvist I. 4-year follow-up of treatment with dental appliance or uvulopalatopharyngoplasty in patients with obstructive sleep apnea: a randomized study. Chest. 2002;121:739–46.PubMedCrossRef
156.
Janson C, Noges E, Svedberg-Randt S, Lindberg E. What characterizes patients who are unable to tolerate continuous positive airway pressure (CPAP) treatment? Respir Med. 2000;94:145–9.PubMedCrossRef
157.
Ferguson KA, Heighway K, Ruby RR. A randomized trial of laser-assisted uvulopalatoplasty in the treatment of mild obstructive sleep apnea. Am J Respir Crit Care Med. 2003;167:15–9.PubMedCrossRef
158.
Larrosa F, Hernandez L, Morello A, Ballester E, Quinto L, Montserrat JM. Laser-assisted uvulopalatoplasty for snoring: does it meet the expectations? Eur Respir J. 2004;24:66–70.PubMedCrossRef
159.
Aurora RN, Casey KR, Kristo D, Auerbach S, Bista SR, Chowdhuri S, Karippot A, Lamm C, Ramar K, Zak R, et al. Practice parameters for the surgical modifications of the upper airway for obstructive sleep apnea in adults. Sleep. 2010;33:1408–13.PubMed
160.
Powell N, Riley R, Guilleminault C, Troell R. A reversible uvulopalatal flap for snoring and sleep apnea syndrome. Sleep. 1996;19:593–9.PubMed
161.
Neruntarat C. Uvulopalatal flap for snoring on an outpatient basis. Otolaryngol Head Neck Surg. 2003;129:353–9.PubMedCrossRef
162.
Neruntarat C. Genioglossus advancement and hyoid myotomy under local anesthesia. Otolaryngol Head Neck Surg. 2003;129:85–91.PubMedCrossRef
163.
Li HY, Li KK, Chen NH, Wang CJ, Liao YF, Wang PC. Three-dimensional computed tomography and polysomnography findings after extended uvulopalatal flap surgery for obstructive sleep apnea. Am J Otolaryngol. 2005;26:7–11.PubMedCrossRef
164.
Li HY, Huang YS, Chen NH, Fang TJ, Liu CY, Wang PC. Mood improvement after surgery for obstructive sleep apnea. Laryngoscope. 2004;114:1098–102.PubMedCrossRef
165.
Li HY, Chen NH, Shu YH, Wang PC. Changes in quality of life and respiratory disturbance after extended uvulopalatal flap surgery in patients with obstructive sleep apnea. Arch Otolaryngol Head Neck Surg. 2004;130:195–200.PubMedCrossRef
166.
Li HY, Chen NH, Lee LA, Shu YH, Fang TJ, Wang PC. Use of morphological indicators to predict outcomes of palatopharyngeal surgery in patients with obstructive sleep apnea. ORL J Otorhinolaryngol Relat Spec. 2004;66:119–23.PubMedCrossRef
167.
Li HY, Li KK, Chen NH, Wang PC. Modified uvulopalatopharyngoplasty: The extended uvulopalatal flap. Am J Otolaryngol. 2003;24:311–6.PubMedCrossRef
168.
Neruntarat C. Long-term results of palatal implants for obstructive sleep apnea. Eur Arch Otorhinolaryngol. 2011;268:1077–80.PubMedCrossRef
169.
Steward DL, Huntley TC, Woodson BT, Surdulescu V. Palate implants for obstructive sleep apnea: multi-institution, randomized, placebo-controlled study. Otolaryngol Head Neck Surg. 2008;139:506–10.PubMedCrossRef
170.
Ho WK, Wei WI, Chung KF. Managing disturbing snoring with palatal implants: a pilot study. Arch Otolaryngol Head Neck Surg. 2004;130:753–8.PubMedCrossRef
171.
Friedman M, Schalch P, Lin HC, Kakodkar KA, Joseph NJ, Mazloom N. Palatal implants for the treatment of snoring and obstructive sleep apnea/hypopnea syndrome. Otolaryngol Head Neck Surg. 2008;138:209–16.PubMedCrossRef
172.
Nordgard S, Hein G, Stene BK, Skjostad KW, Maurer JT. One-year results: palatal implants for the treatment of obstructive sleep apnea. Otolaryngol Head Neck Surg. 2007;136:818–22.PubMedCrossRef
173.
Friedman M, Schalch P, Joseph NJ. Palatal stiffening after failed uvulopalatopharyngoplasty with the Pillar Implant System. Laryngoscope. 2006;116:1956–61.PubMedCrossRef
174.
Walker RP, Levine HL, Hopp ML, Greene D, Pang K. Palatal implants: a new approach for the treatment of obstructive sleep apnea. Otolaryngol Head Neck Surg. 2006;135:549–54.PubMedCrossRef
175.
Gillespie MB, Wylie PE, Lee-Chiong T, Rapoport DM. Effect of palatal implants on continuous positive airway pressure and compliance. Otolaryngol Head Neck Surg. 2011;144:230–6.PubMedCrossRef
176.
Li KK, Powell NB, Riley RW, Guilleminault C. Temperature-controlled radiofrequency tongue base reduction for sleep-disordered breathing: Long-term outcomes. Otolaryngol Head Neck Surg. 2002;127:230–4.PubMedCrossRef
177.
Riley RW, Powell NB, Guilleminault C. Inferior sagittal osteotomy of the mandible with hyoid myotomy-suspension: a new procedure for obstructive sleep apnea. Otolaryngol Head Neck Surg. 1986;94:589–93.PubMed
178.
den Herder C, van Tinteren H, de Vries N. Hyoidthyroidpexia: a surgical treatment for sleep apnea syndrome. Laryngoscope. 2005;115:740–5.CrossRef
179.
Riley RW, Powell NB, Guilleminault C. Obstructive sleep apnea and the hyoid: a revised surgical procedure. Otolaryngol Head Neck Surg. 1994;111:717–21.PubMedCrossRef
180.
Stuck BA, Neff W, Hormann K, Verse T, Bran G, Baisch A, Duber C, Maurer JT. Anatomic changes after hyoid suspension for obstructive sleep apnea: an MRI study. Otolaryngol Head Neck Surg. 2005;133:397–402.PubMedCrossRef
181.
2Prinsell JR. Maxillomandibular advancement surgery in a site-specific treatment approach for obstructive sleep apnea in 50 consecutive patients. Chest. 1999;116:1519–29.PubMedCrossRef
182.
Riley RW, Powell NB, Guilleminault C. Maxillofacial surgery and obstructive sleep apnea: a review of 80 patients. Otolaryngol Head Neck Surg. 1989;101:353–61.PubMed
183.
Hochban W, Brandenburg U, Peter JH. Surgical treatment of obstructive sleep apnea by maxillomandibular advancement. Sleep. 1994;17:624–9.PubMed
184.
Riley RW, Powell NB, Guilleminault C. Obstructive sleep apnea syndrome: a review of 306 consecutively treated surgical patients. Otolaryngol Head Neck Surg. 1993;108:117–25.PubMed
185.
Fujita S, Conway WA, Zorick FJ, Sicklesteel JM, Roehrs TA, Wittig RM, Roth T. Evaluation of the effectiveness of uvulopalatopharyngoplasty. Laryngoscope. 1985;95:70–4.PubMedCrossRef
186.
Chen SC, Shi S, Zheng HL, Chen DH, Zhu MH, Liu F, Tang HH, Wang K. Combination of genioglossus advancement by non-trephine technic with uvulopalatopharyngoplasty for treatment of obstructive sleep apnea-hypopnea syndrome. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009;44:815–8.PubMed
187.
Hendler BH, Costello BJ, Silverstein K, Yen D, Goldberg A. A protocol for uvulopalatopharyngoplasty, mortised genioplasty, and maxillomandibular advancement in patients with obstructive sleep apnea: an analysis of 40 cases. J Oral Maxillofac Surg. 2001;59:892–7. discussion 898–899.PubMedCrossRef
188.
Sundaram S, Bridgman SA, Lim J, and Lasserson TJ. Surgery for obstructive sleep apnoea. Cochrane Database Syst Rev 2005;CD001004.
189.
Paoli JR, Lauwers F, Lacassagne L, Tiberge M, Dodart L, Boutault F. Craniofacial differences according to the body mass index of patients with obstructive sleep apnoea syndrome: cephalometric study in 85 patients. Br J Oral Maxillofac Surg. 2001;39:40–5.PubMedCrossRef
190.
Kao YH, Shnayder Y, Lee KC. The efficacy of anatomically based multilevel surgery for obstructive sleep apnea. Otolaryngol Head Neck Surg. 2003;129:327–35.PubMedCrossRef
191.
Liu SA, Li HY, Tsai WC, Chang KM. Associated factors to predict outcomes of uvulopharyngopalatoplasty plus genioglossal advancement for obstructive sleep apnea. Laryngoscope. 2005;115:2046–50.PubMedCrossRef
Metadata
Title
Non-positive airway pressure therapy for obstructive sleep apnea
Authors
Behrouz Jafari
Francoise Roux
Publication date
01-06-2012
Publisher
Current Science Inc.
Published in
Current Pulmonology Reports / Issue 2/2012
Electronic ISSN: 2199-2428
DOI
https://doi.org/10.1007/s13665-012-0016-y

Other articles of this Issue 2/2012

Current Pulmonology Reports 2/2012 Go to the issue

Pleural Diseases and Mesothelioma (YCG Lee, Section Editor)

Diagnosis of pleural infection: state-of-the-art

Pleural Diseases and Mesothelioma (YCG Lee, Section Editor)

Emerging therapies for malignant pleural mesothelioma

Pleural Diseases and Mesothelioma (YCG Lee, Section Editor)

Common iatrogenic pleural complications

Sleep Medicine (TL Lee-Chiong and V Castronovo, Section

Portable monitoring in sleep apnea

Sleep Medicine (TL Lee-Chiong and V Castronovo, Section Editors)

Respiratory medications and sleep

Sleep Medicine (TL Lee-Chiong and V Castronovo, Section Editors)

CPAP: enhancing its use
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits